New onset atrial fibrillation (NOAF) research hub

Investigating the clinical and cost-effectiveness of two different drugs (amiodarone and beta blockers) to treat patients with new-onset atrial fibrillation whilst in the intensive care unit

This UK study looks at two standard NHS medicines for an irregular heartbeat that can start during a stay in intensive care. Researchers want to find out whether drugs called beta-blockers or a drug called amiodarone work best to return the heart to a normal rhythm safely.